Treace Medical Concepts' GAAP loss for 3 months of 2022 was $9.036 million, up 3.7 times from $2.432 million in the prior year. Revenue increased 55.3% to $29.047 million from $18.707 million a year earlier.
Treace Medical Concepts' GAAP loss for 3 months of 2022 was $9.036 million, up 3.7 times from $2.432 million in the prior year. Revenue increased 55.3% to $29.047 million from $18.707 million a year earlier. 
English (US) 